ArticleClinical Medicine Insights. Oncology2025

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.

Xiaojie Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.